The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COSTEM 2022 | The state of stem cell transplantation for multiple myeloma in Brazil
Vanderson Rocha, MD, Fundação Pró-Sangue Hemocentro de São Paulo & Universidade de São Paulo, Sao Paulo, Brazil, describes current issues patients with multiple myeloma face receiving stem cell transplantation in Brazil. Despite transplantation being a key treatment strategy, only one in five patients with multiple myeloma will be able to receive a transplant due to a lack of transplant units and resources. This interview took place at the 7th Congress on Controversies in Stem Cell Transplantation and Cellular Therapies (COSTEM) in Berlin, Germany.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
